CIPA Guide to the Patents Acts

The CIPA Guide To the Patents Act, 8th edition, is a must-have for any practitioner advising about patents.
The Guide brings together the expertise of over 25 highly respected professionals including patent attorneys, solicitors and members of the Bar, all individually selected for their expert knowledge.
Sets out the acts section by section and, where appropriate, the Features the Patents Act, 1977 and relevant provisions of the Copyright, Designs and Patents Act, 1988 together with relevant EU treaties and directives
Includes the full text of the Acts, section-by-section
Provides the corresponding provisions of the Paris Convention, the TRIPS Treaty, the PCT and the EPC
Includes the UK Patents Rules and the Civil Procedure Rules and Practice Directions relevant to each section
Features the decisions relevant to each section of the UK IP Office and courts and of the EPO Appeal Boards
Includes selected decisions of the US courts
Provides a detailed commentary and analysis of the practical working of each section and of the significance of the decisions handed down under it
Features coverage of developments in the fields of software, biotechnology and supplementary protection certificates for pharmaceuticals
Refers to over 3300 decided cases
NEW TO THIS EDITION
The 8th edition offers coverage of legislative and jurisprudence developments to end June 2015, including:
Amendments introduced by recent legislation including the Intellectual Property Act, 2014, the Patents (European Patent with Unitary Effect and Unified Patents Court) Order 2015, the Patents (Amendment) Rules 2014 and updates to CPR Practice Direction 63.
Substantial commentary on landmark decisions including:
Generics (UK) Ltd t/a Mylan v Warner Lambert [2015] EWHC 2548 (Pat) (second medical use claims)
Lantana Ltd v Comptroller General of Patents [2014] EWCA Civ 1463 (patentable subject matter)
Aga Medical Corp v Occlutech (UK) Ltd [2014] EWHC 2506 (Pat) (confidentiality)
Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat) (obviousness; common general knowledge)
Idenix v Gilead [2014] EWHC 3916 (generic claim for pharmaceutical compounds; rationale supporting effectiveness)
International Stem Cell Corporation (Judgment) [2014] EUECJ C-364/13 (human embryo)
Eli Lilly & Company v Human Genome Sciences Inc [2014] EWHC 2404 (Pat) (SPC regulation)
T 1363/12 SAMSUNG/Reinforcement (test for added subject-matter)
G 3/14 Examination of clarity objections G 2/12 Tomatoes II and G 2/13 Broccoli II (product claims; essentially biological processes)
Commentary on the many other decisions recently handed down which may be relevant to specific practice iss